Parasite-specific protein or metabolic pathway (null)

“Parasite-specific proteins or metabolic pathways" refers to enzymes, proteins, or complete metabolic pathways that are unique to, or highly divergent in, parasitic organisms compared to their mammalian hosts. These molecules are often critical for parasite viability, proliferation, infectivity, or survival within the host. Because they are absent or significantly different in host organisms, they represent attractive targets for selective antiparasitic drug development[2][6]. Examples include the nonmevalonate isoprenoid biosynthesis pathway in the malaria parasite Plasmodium falciparum (targeted by fosmidomycin), specific enzymes in Leishmania, and unique metabolic functions identified through genome-scale metabolic models of parasites like Brugia malayi or Leishmania[1][3][4][5]. This entry is problematic for structured biomedical databases because it is not a single, well-defined molecular target but a catch-all term for many possible molecular entities. It should be replaced by the specific protein, enzyme, or metabolic pathway under investigation, such as "Deoxyxylulose phosphate reductoisomerase" or "Glycosylphosphatidylinositol biosynthesis pathway," so as to allow precise mapping and information retrieval.

Other names

Parasite-unique proteinsParasite-unique metabolic pathwaysParasite-selective targets

Inhibition of essential metabolic enzymes unique to the parasite and absent in the host[6]; Disruption of parasite-specific biochemical pathways necessary for survival or infectivity[2][5]